"Intrepid Research is committed to improving your health through the advancements gained from clinical research. Our clinical research experience, state of-the-art facilities, and oversight by Physicians with over 25 years of clinical research experience truly sets us apart. We encourage you to participate in one of our many clinical trials."

During the past decade, Intrepid Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Intrepid Research" #1 sponsor was "Apnimed" with 3 trials, followed by "Harmony Biosciences, LLC" with 3 trials sponsored, "Jazz Pharmaceuticals" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Eisai Inc." with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intrepid Research" #1 collaborator was "LivaNova" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Intrepid Research" are "Idiopathic Hypersomnia" (4 trials), "Narcolepsy" (4 trials), "Obstructive Sleep Apnea" (4 trials), "Excessive Daytime Sleepiness" (3 trials) and "Narcolepsy With Cataplexy" (3 trials). Many other conditions were trialed in "Intrepid Research" in a lesser frequency.

Most popular intervention types in "Intrepid Research" are "Drug" (18 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "JZP-258" (3 trials), "AD504" (2 trials), "TAK-994" (2 trials) and "AD109" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intrepid Research" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Intrepid Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Intrepid Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Intrepid Research, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".